3,984 Shares in DaVita Inc. (NYSE:DVA) Purchased by SoundView Advisors Inc.

SoundView Advisors Inc. acquired a new stake in DaVita Inc. (NYSE:DVA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,984 shares of the company’s stock, valued at approximately $595,000. DaVita accounts for approximately 0.2% of SoundView Advisors Inc.’s holdings, making the stock its 24th largest holding.

A number of other hedge funds also recently made changes to their positions in the business. Transcendent Capital Group LLC bought a new stake in shares of DaVita during the 3rd quarter worth about $25,000. SBI Securities Co. Ltd. acquired a new stake in DaVita during the fourth quarter worth approximately $41,000. Quarry LP bought a new stake in shares of DaVita during the third quarter worth approximately $60,000. Venturi Wealth Management LLC boosted its holdings in shares of DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after acquiring an additional 152 shares during the period. Finally, Versant Capital Management Inc grew its position in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares during the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Cowen restated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $166.33.

DaVita Price Performance

DaVita stock opened at $151.72 on Tuesday. The stock’s fifty day moving average price is $159.47 and its two-hundred day moving average price is $157.95. The firm has a market cap of $12.14 billion, a PE ratio of 14.13, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, research analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.